Object Pharma, Inc.


Developing botulinum neurotoxins for unmet needs in aesthetic and therapeutic markets.

Employees

1-10

Links


Org chart

Kenton Abel
Chief Executive Officer
Collapse
Dan Radecki
Vice President Of Research And Development
Dale Hollingshead
Chief Financial Officer

Teams

This company has no teams yet